Corcept Therapeutics EBIT 2010-2025 | CORT

Corcept Therapeutics EBIT for the quarter ending March 31, 2025 was $0.003B, a 88.42% decline year-over-year.

  • Corcept Therapeutics 2024 EBIT was 0.137B, a 27.66% increase from 2023.
  • Corcept Therapeutics 2023 EBIT was 0.107B, a 4.75% decline from 2022.
  • Corcept Therapeutics 2022 EBIT was 0.113B, a 9.51% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Corcept Therapeutics EBIT 2010-2025 | CORT

  • Corcept Therapeutics 2024 EBIT was 0.137B, a 27.66% increase from 2023.
  • Corcept Therapeutics 2023 EBIT was 0.107B, a 4.75% decline from 2022.
  • Corcept Therapeutics 2022 EBIT was 0.113B, a 9.51% decline from 2021.

EBIT can be defined as earnings before interest and taxes.